Tirzepatide vs Semaglutide: Which GLP-1 Is Better?

Tirzepatide (dual agonist, 15-22.5% loss) outperforms semaglutide (single agonist, 10-15% loss). Both available NOW through telehealth.

FeatureTirzepatideSemaglutide
Weight Loss15-22.5%10-15%
MechanismDual agonist (GLP-1 + GIP)Single agonist (GLP-1 only)
Cost (Telehealth)$179-499/mo$349-599/mo
Side EffectsModerate (nausea 20-30%)Moderate (nausea 15-25%)

The GIP Advantage

Why tirzepatide wins: Adding GIP receptor activation produces 50-100% MORE weight loss than GLP-1 alone.

  • • GLP-1 (both drugs): Appetite suppression, slower digestion
  • • GIP (tirzepatide only): Enhanced insulin response, increased fat metabolism, reduced food intake

Result: 200 lb person loses 30-45 lbs with tirzepatide vs 20-30 lbs with semaglutide.

Cost Comparison: Tirzepatide Wins

Tirzepatide (BETTER VALUE)

$179-499/mo

  • ✅ 15-22.5% weight loss
  • ✅ CHEAPER than semaglutide
  • ✅ Better results
Start Tirzepatide →

Semaglutide

$349-599/mo

  • • 10-15% weight loss
  • • MORE expensive
  • • Older technology

Bottom line: Tirzepatide costs LESS and works BETTER. Easy choice.

Choose Tirzepatide—Better Results, Lower Cost

15-22.5% weight loss, $179-499/mo. Available NOW.

Get Started ($179/mo) →